chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning her 44 month old son with no pertinent medical history, no known drug reactions who in December 2007 (also reported as when he was 15 month old), was vaccinated SQ with a 0.5 ml first and only dose of VARIVAX (Merck) (Lot#: not reported). Concomitant therapy included vitamins (unspecified). The physician reported that her son developed 10 to 12 vesicular lesions on his legs and some could be on his neck after receiving VARIVAX (Merck). The physician also stated that her son had about 10 vesicles below both knees mostly around the ankle and a few on the calf. The physician's son was also lethargic. The physician requested a VZV Analysis by PCR (Polymerase Chain Reaction) and wanted to send viral isolates. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Additional information is not expected.
Died; Felt bad all day Saturday and Sunday/wasn't feeling good; This is a spontaneous report from a contactable consumer or other non hcp. A 63-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on 09Apr2021(at the age of 63- year-old) as dose 2, single for covid-19 immunization. Medical history included Smoker user from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect and Additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as none. The patient did not receive any other vaccines within four weeks prior to the vaccination. AE(s) following prior vaccinations were none. Family Medical History Relevant to AE(s) and Relevant Tests were reported as none. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on 11Mar2021 as dose 1, single for covid-19 immunization. Reporter stated his wife received the first dose on 10Mar and the second on 09Apr2021, which was a Friday evening. He stated she felt bad all-day Saturday(10Apr2021) and Sunday, and she was going to go to the doctor on Monday. The patient went to sleep that night and the last time she spoke to anyone was 11:00 or 11:30 that evening, 11Apr2021. Then no one could get a hold of the patient and was found dead on 12Apr2021. The reporter believed that the patient died that night of 11Apr2021. The patient did not visit to emergency room or physician office. The patient died on 12Apr2021. An autopsy was not performed.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Died
HEADACHE; DOUBLE VISION; SHORT OF BREATH; PAIN IN LEGS; UNUSUALLY TIRED; This spontaneous report received from a patient concerned a 59 year old female. The patient's weight was 101 kilograms, and height was 60 inches. The patient's concurrent conditions included psoriasis, dry eyes, seasonal allergies-non serious, alcohol use, and non-smoker, and other pre-existing medical conditions included patient had no known drug allergies and not asked drug abuse or illicit drug usage.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included ciclosporin for dry eyes, and etanercept for treatment of psoriasis.  On 11-APR-2021, the subject experienced double vision. On 11-APR-2021, the subject experienced short of breath. On 11-APR-2021, the subject experienced pain in legs. On 11-APR-2021, the subject experienced unusually tired. On 12-APR-2021, the subject experienced headache. Treatment medications included: ibuprofen. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from double vision, and pain in legs on 11-APR-2021, and headache on 13-APR-2021, and was recovering from unusually tired, and short of breath. This report was non-serious.
pt presented at store today with a bruise on her upper left calf. she did not remember hitting her leg. she noticed it after her janssen covid vaccine. I advised pt to seek medical attention due to the risk of low platelets/blood clots- under advisement of the EUA.  Pt was going to get looked at Med Express.
This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on thigh) and RASH (rash on leg) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced RASH (rash on thigh) and RASH (rash on leg). At the time of the report, RASH (rash on thigh) and RASH (rash on leg) outcome was unknown. Not Provided  No concomitant medication were provided. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up contains no significant information.
I have had recurring hives, itchy skin, diarrhea, nausea, vomiting, and thrombosis. These symptoms come and go sporadically and last for 1-3 days then go away. They keep coming back and have been for  6 months. I have had no previous issues prior to the vaccine. I have had multiple tests ran amd the doctors cannot find out what is wrong.
Information has been received from a pediatrician who traveled to different sites daily. On 11-MAY-2006, she reported that she had seen a varicella outbreak over the previous 2 weeks. She personally had seen 6 cases and had heard other physicians talking about it as well. All the children were less than 18 years old. The 5 cases were mild break through cases (WAES0608USA05466). The 6th patient was an 8-10 year old male with no pertinent medical history who was vaccinated with Varivax and must have been a nonresponder since he had a severe case of lesions all over his body that were full of pus. The physician prescribed antibiotics because she was afraid the patient's skin would become infected. On 11-MAY-2006, the patient recovered his experience. The physician also noted that she had been practicing for over 18 years and had not seen this type of outbreak. Additional information has been requested.
SOB, nausea, vomiting. Pt went to ER, sx resolved with IVF, discharged home later that night. We did not give vaccine, she had locally, we saw her after ER visit
This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of a rash (arm, neck and chest) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 024M20A and 001B21A) for COVID-19 immunization. No medical history reported. On Mar 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On an unknown date, patient developed a rash (arm, neck and chest). At the time of the report, rash (arm, neck and chest) outcome: unknown. Patient treated with Zyrtec (cetirizine dihydrochloride) cream. This case linked to MOD-2021-021889 (patient link).
Pt. came on 10/20/2010 for flu shot. Received Flu shot IM (L) deltoid. Called c/o dizziness, vomiting, diarrhea. T.C, called x 2 - feeling ?, C x 1 - left a message.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored dose of GARDASIL 9 lot # M041213, expiration date 22-JUN-2019, (strength, dose and route of administration were not reported) for prophylaxis. The vaccine was exposed to 31 Fahrenheit degree (F) or colder (25F) for 1 hour 53 minutes and 47 Fahrenheit degree (F) to 77 Fahrenheit degree (F) (49F) for 3 hours 59 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects reported. There was no product quality complaint (PQC) involved. This is one of the two reports received from same reporter. Sender's Comments: US-009507513-1708USA003070.
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 06-JUL-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" which had a lot number of K007828 and expiration date on 02-MAR-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified date, the GARDASIL vaccine had three temperature excursions; one for 712 hours with lowest recorded temperature of 33 F (0.555555556 Celsius) other one for 216 hours with lowest recorded temperature of 32 F (0 Celsius) and other for 64 hours with lowest recorded temperature of 34 F (1.111111111 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Dizziness; Having Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and PYREXIA (Having Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and PYREXIA (Having Fever). At the time of the report, DIZZINESS (Dizziness) and PYREXIA (Having Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were not reported.  No treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: Significant follow up received. Having Fever a new Event added.
Fever of 100+ and would  not respond to Tylenol; body aches and chills and extreme headaches
Developed large painful swelling under left arm, about the size of an orange, not still swollen but not painful.
Patient reported severe arm pain 6 days after injection. Also numbness and tingling in her hands.
hives on right arm; itchy on right arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on right arm) and PRURITUS (itchy on right arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced URTICARIA (hives on right arm) and PRURITUS (itchy on right arm). At the time of the report, URTICARIA (hives on right arm) and PRURITUS (itchy on right arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
DEVELOPED FEVER STARTING DAY 6 AFTER IMMUNIZATIONS. HIGHEST FEVER 101.5. MILD RHINORRHEA, CLEAR, CONCURRENT. RASH DEVELOPED SUDDENLY STARTING DAY 10 AFTER IMMUNIZATIONS. FINE MACULOPAPULAR RASH OVER UPPER TORSO BACK>FRONT. SOME ON PROXIMAL ARMS/ LEGS.
Period was over 2 weeks late; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient's period was over two weeks late. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event period was over two weeks late was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Patient experienced itching from the top of the immunized arm to the elbow. She had a large bump on the inside of her elbow that she said was hard and painful.
Shingles on Right Thigh, groin and lower back appeared after 2 days.
day 1. presyncope, resolved within minutes. Day  12. experienced positional vertigo. has lasted 5 d so far
Pt recvd MMR/DTP on 27JAN90; 9 days following vax pt exp a sz;
Low grade fever; Chills; This is a spontaneous report from a contactable consumer reported for self. This female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose (Reason for no lot number: don't know if it is F179899) for covid-19 immunisation. She had low grade fever she mentioned 99.8, and she had chills. Outcome of the events was unknown.  Information on Lot/Batch has been requested.
Less than 8 hours after vaccination, Pt  began to run a high fever (103.7).  She had trouble walking and was shivering intensely.  With medication (Tylenol/Ibuprofen alternated) we were able to control the fever but it maintained between 101 and 102.  When the medicine wore off, it quickly rose again to over 103 degrees.  Pt fever never dropped below 101 degrees for 3 full days.  During the 4th and 5th days, she continued to run a fever, but with medication her fever was controlled (between 99 and 100.9 degrees).  On days 2 and 3 we consulted virtually with our pediatrician, who encouraged us to keep monitoring her fever and bring her in on the 5th day if she continued to have symptoms to check for other illnesses.  Pt went to the pediatrician on day 5, and no other illnesses were noted.  We would like her dosage to be investigated.  Due to the intensity of her fever and absence of other symptoms, we are concerned that she could have been given the wrong dose.  She had her second vaccine dose on 12/27/21  and her only side effect was a sore arm.
This man is 74 years old. He received his 12 month booster (2nd dose) of Prevnar; Had a fever; Intense muscle pain in his arm at the injection site; This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A 74-year-old male patient received second dose (referred to as 12 month booster) pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 13), via an unspecified route of administration in the arm on an unspecified date at a single dose for immunization in the physician's office. Medical history included cardiac events and low tolerance for pain. The patient's concomitant medications were not reported. On an unspecified date, it was realized that the patient experienced inappropriate dose of vaccine administered as this man was 74-years-old and received his 12 month booster (2nd dose) of pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein). The patient left the doctor's office at 11 am on 04Jun2019 reported as yesterday, and by dinner, had a fever of 101 and intense muscle pain in his arm at the injection site. He finished a light dinner and immediately went to sleep. He woke up the next day (05Jun2019) and felt significantly better and his temperature has returned to 98.6. The adverse events took place after use of the vaccine. The outcome of fever was recovered on 05Jun2019 while recovering for the event of 'intense muscle pain in his arm at the injection site'. The information regarding the batch/lot number has been requested.
Patient reports her right arm is red, itching and swollen. She said the swelling, itching and swelling extended from the middle of her back, around the right side of her body, and up to her right breast. She also reports that she had a fever on 11/22/2018 that has since resolved. Patient reports it is very painful. She spoke with her PCP who directed her to go to the emergency room but she did not go because it was a holiday and she was not having trouble breathing. She spoke with a pharmacist at store who instructed her to take BENADRYL which she did. Patient reports that it is better today than it was before.
bruising immediately following injection for several days, itchy arm, redness about 2" diameter at injection site about a week after injection  general fatigue, increased difficulty sustaining cardio around time redness appeared
Information has been received from a healthcare professional referring to multiple unspecified patients. On unknown dates the patients were vaccinated with doses of ROTATEQ (lot # L029934, expiration date 01-MAY-2017; lot # L027719, expiration date 28-APR-2017; lot # L013206, expiration date 29-JAN-2017), which were improperly stored at 0.4 centigrade with total cumulative time of 518 hours. There was no previous temperature excursion. No adverse effects reported. This is one of several cases received from the same source. Additional information has been requested.
I got an smart watch for my birthday; it told me that I was in A-fib. I made an appointment with my doctor who ordered an EKG that said everything looked fine. He also ordered, a Body Guardian mini monitor for me to wear for two weeks. When I went in for the results it did show that I was in A-fib. am now taking Eliquis and Metoprolol Succinate to help with the A-fib. Currently my blood pressure is normal, and my heart is not showing any signs of A-fib. I was referred to a cardiologist by my family physician to confirm the results and medications. She changed my Metoprolol to twice a day. I do not feel like I am getting better, I have no energy and I am tired all the time.
SWELLING; RAISED RED MARK UNDER THE INJECTION SITE DESCRIBED THAT IT LOOKED LIKE WICKED SPIDER BITE; RASH; This spontaneous report received from a patient. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 11:00 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 31-MAR-2021, the subject experienced swelling. On 31-MAR-2021, the subject experienced raised red mark under the injection site described that it looked like wicked spider bite. On 31-MAR-2021, the subject experienced rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash, swelling, and raised red mark under the injection site described that it looked like wicked spider bite. This report was non-serious.
shoulder pain; shortness of breath; cough; tickle sensation in my chest; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Mar2021 (Lot number: Er2613) as dose 1, single and administered in arm right, administration date 12Apr2021 (Lot number: Er8731) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLONASE [FLUTICASONE PROPIONATE].  The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "shoulder pain"; DYSPNOEA (non-serious), outcome "unknown", described as "shortness of breath"; COUGH (non-serious), outcome "unknown", described as "cough"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "tickle sensation in my chest". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Other medications in two weeks: Flonase. If other vaccine in four weeks: No. If COVID prior vaccination: No. If COVID tested post vaccination: Yes. Adverse event: She had shoulder pain for over three months also she had a shortness of breath and cough tickle sensation in her chest that comes and goes every day every hour.  Follow-up attempts are completed. No further information is expected.
Subsequent to vax, this pt experienced fever swelling, and arm pain with hand numbness. The pt sought unspecified medical treatment. The symptoms subsided within a few days without treatment. Ice packs were applied locally. On an unspecified date the pt recovered.
I will get more information soon. But I was told that the patient has experienced severe vaccines adverse reaction the day after he received the vaccines.
Given 1st HPV4 on 11-14-07 about 2 weeks after received vaccine began to have symptoms of depression, increased crabby, feeling of doom, emotional. Went to the doctors in March when symptoms didn't go away. Did not notice any change after the 2nd dose. While getting the 3rd dose told this info to nurse and VAERS was completed
pt devel pink hands & wrist & feet & ankles 5-10 min p/vax;child otherwise well;no resp or swallowing problems, given DPH & observed in office;pt returned to nl;all redness & pinkness resolved;inj site always nl;
Arm pain started the next evening after the shot; but pain went away after 3 days; but the pain returned more severely 7 days later.   The pain both times was so severe that the arm was immobilized.   And the second bout of pain involved the hand, arm, neck, and ear ache.    The pain slightly subsided yesterday, but came back more intense today.   raises concern about incorrect injection technique causing severe shoulder pain (SIRVA)
Chills, fever, body aches, foggy vision, foggy brain, extreme pain in injection site with giant bruise, coughing, exhaustion  Took Tylenol and Aleve The symptoms started less than 12 hours after the 2nd shot with the arm pain being immediate Took 5 days for the fever to break and still suffering with brain fog and exhaustion.  I went from being healthy to feel sick. I never get sick. My whole family got covid and I'm the only one who didn't catch it living in the house with them. I never go to the doctor because I don't get sick. I'm not even set up with a primary care doctor since I had my last child 34 years ago because I don't get sick. I very much regret getting this vaccine. I hope to return to myself soon. I have no energy and it's been 8 days since my 2nd dose of moderna.
Fever, hot and cold flashes, extreme body aches all over, headache, ringing in both ears, cramps in both legs, shooting nerve pain up and down both legs, nausea, loss of apatite, agitation, sleepiness.